Oncology Business Week

GPC Biotech, AG - Data on satraplatin presented at AACR prostate cancer meeting

Genomic Health Inc. - Molecular test predicts recurrence risk and who will benefit from chemotherapy

Guys Hospital, London - Editorial highlights issues facing acceptance of cancer genetics uses

Harvard University - Caveolin-1 is the molecular target of the proteasome inhibitor bortezomib

HealthTronics, Inc. - Companies enter marketing agreement for FastPack System

Hospital de Cruces - Concurrent gene and protein analyses expose p53 status in liver cancer patients

Human Genome Sciences, Inc. - Patient enrollment completed for HGS-ETR1 trial in non-small cell lung cancer

ILEX Oncology, Inc. - U.S. FDA committee recommends accelerated clofarabine approval for ALL

IVAX Corporation - Pharmaceutical company confirms, first to market Paxene in Spain

InScope - PillCam ESO receives marketing clearance from U.S. FDA

Innovive Pharmaceuticals, Inc. - Steven Kelly named president, CEO of oncology-focused pharmaceutical company

Institut Jules Bordet - Validation study paves way for large-scale trial of personalized therapy

Intl. Agency for Research on Cancer, France - European study highlights increase in childhood cancer over past 3 decades

Johns Hopkins University - MRI useful for detection, but doesn't eliminate need for biopsy

Kaiser Permanente - Survey finds Americans believe obesity treatment should be included health plans

Lifeline Biotechnologies, Inc. - Peer-reviewed journal includes articles on breast ductoscopy product

Ludwig-Maximilians-University Munich - Translocation of foreign antigens by Yersinia leads to T-cell priming

M.D. Anderson Cancer Center - Half of relapsed CLL patients respond to two biologics with chemotherapy

Maxim Pharmaceuticals - Pharma company announces manuscript publication for anticancer drug

Mayo Clinic - Promising next-generation treatments for multiple myeloma

Medical University of Vienna - Endostatin expression is differential at the fetal-maternal interface

Montreal General Hospital - Mutation panel described for screening BRCA1/2 mutations in French Canadians

NeoPharm, Inc. - First patient given dose in phase I study of LErafAON

Neothermia Corporation - Cancer diagnostics company announces new biopsy probes

Nerviano Medical Science - p53-dependent replication checkpoint is defective in cancer cells

New York University - Add an "E" to the alphabet for identifying melanoma

New York University - The benefit/risk ratio for anti-TNF-alpha agents has been favorable

Norwegian Radium Hospital, Oslo - Mathematical model predicts time to neutrophil recovery after HD chemotherapy

Novacea Inc. - Biopharma company presents study results for anticancer agent at conference

PhotoCure ASA y - Hexvix marketing application for bladder cancer diagnosis authorized in Europe

Princess Margaret Hospital - Pro-apoptotic Bim_s treats and prevents xenografted tumors

Procyon Biopharma Inc. - Metastatic hormone-refractory prostate cancer treatment trial results reported

R2 Technology, Inc. - Frost & Sullivan recognizes ImageCheckerCT CAD System as Product of the Year

Rita Medical Systems, Inc. - Lung cancer survival statistics reported in trial using radiofrequency ablation

Robert Alonso - Clinical trials for agent to treat methamphetamine addiction initiated

Roswell Park Cancer Institute - Cyclodextrin can enhance transdermal delivery by electroporation

Roswell Park Cancer Institute - Potential ovarian cancer susceptibility allele of low penetrance identified

Royal College of Surgeons in Ireland - Human telomerase reverse transcriptase may have prognostic value

Saarland University - Cytotoxic T cell responses toward NY-ESO-1 protein examined

Sanofi-Aventis Group - Data show ELOXATIN-based therapy combined with Bevacizumab improves survival

Sichuan University - Rofecoxib and octreotide combine to stop gastric cancer cell proliferation

iCad, Inc. - Imaging equipment maker introduces compact system for low-use mammography sites